enGene Ownership | Who Owns enGene?
enGene Ownership Summary
enGene is owned by 79.23% institutional investors, 13.63% insiders, and 7.15% retail investors. Fcpm iii services b.v. is the largest institutional shareholder, holding 18.88% of ENGN shares.
ENGN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | enGene | 79.23% | 13.63% | 7.15% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fcpm iii services b.v. | 9.63M | 18.88% | $35.06M |
Vr adviser | 5.05M | 9.89% | $18.37M |
Kynam capital management, lp | 4.99M | 9.79% | $18.18M |
Deep track capital, lp | 4.56M | 8.93% | $16.59M |
Blue owl capital lp | 3.73M | 7.31% | $13.57M |
Cormorant asset management, lp | 2.32M | 4.55% | $8.46M |
Point72 asset management | 1.21M | 2.37% | $4.40M |
Adage capital partners gp | 1.00M | 1.96% | $3.64M |
Orbimed advisors | 677.98K | 1.33% | $2.47M |
Omega fund management | 526.36K | 1.03% | $1.92M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Fcpm iii services b.v. | 9.63M | 9.50% | $35.06M |
Blue owl capital lp | 3.73M | 4.38% | $13.57M |
Kynam capital management, lp | 4.99M | 1.96% | $18.18M |
Vr adviser | 5.05M | 1.38% | $18.37M |
Omega fund management | 526.36K | 1.24% | $1.92M |
Cormorant asset management, lp | 2.32M | 0.63% | $8.46M |
Deep track capital, lp | 4.56M | 0.53% | $16.59M |
Sphera funds management | 504.41K | 0.43% | $1.84M |
Vestal point capital, lp | 370.00K | 0.07% | $1.35M |
Orbimed advisors | 677.98K | 0.06% | $2.47M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blue owl capital lp | 3.73M | 4.38% | 448.73K |
Affinity asset advisors | 77.00K | 0.04% | 77.00K |
Paloma partners management | 10.32K | 0.01% | 10.32K |
Cresset asset management | 10.00K | 0.00% | 10.00K |
Adar1 capital management | 27.79K | 0.02% | 3.99K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Adage capital partners gp | 1.00M | 0.01% | -571.64K |
Orbimed advisors | 677.98K | 0.06% | -213.64K |
Mai capital management | 2.92K | 0.00% | -75.14K |
Point72 asset management | 1.21M | 0.01% | -32.89K |
Sphera funds management | 504.41K | 0.43% | -23.96K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Affinity asset advisors | 77.00K | 0.04% | 77.00K | $280.28K |
Paloma partners management | 10.32K | 0.01% | 10.32K | $37.56K |
Cresset asset management | 10.00K | 0.00% | 10.00K | $36.40K |
Raymond james financial | 2.07K | - | 2.07K | $7.53K |
Nbc securities | 380.00 | 0.00% | 380.00 | $1.00 |
Sold Out
Holder | Change |
---|---|
Ubs group | -1.20K |
Sectoral asset management | -11.70K |
Two sigma investments, lp | -15.83K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 37 | 19.35% | 40,420,485 | -1.27% | 79 | 1.23% | 13 | 44.44% | 9 | 12.50% |
Mar 31, 2025 | 31 | -8.82% | 40,941,351 | -0.88% | 80 | 1.22% | 9 | -59.09% | 8 | 14.29% |
Dec 31, 2024 | 34 | 13.33% | 41,304,528 | 20.44% | 81 | 1.34% | 22 | 37.50% | 7 | 75.00% |
Sep 30, 2024 | 30 | - | 34,293,391 | 5.17% | 77 | 1.42% | 16 | 14.29% | 4 | -33.33% |
Jun 30, 2024 | 30 | -3.23% | 32,608,601 | 3.00% | 73 | 1.15% | 14 | -41.67% | 6 | 100.00% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.00M |
Oct 07, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $77.53K |
Oct 04, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $39.24K |
Oct 03, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $37.40K |
Oct 08, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.28K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | 7 | - |
2024 Q3 | 4 | - |
ENGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools